(ALV) Allianz SE VNA O.N. - Overview
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE0008404005
Stock: Insurance, Investments, Banking
Total Rating 35
Risk 67
Buy Signal -0.29
| Risk 5d forecast | |
|---|---|
| Volatility | 19.5% |
| Relative Tail Risk | 3.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.13 |
| Alpha | -3.52 |
| Character TTM | |
|---|---|
| Beta | 0.287 |
| Beta Downside | 0.036 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.35% |
| CAGR/Max DD | 2.05 |
EPS (Earnings per Share)
Revenue
Description: ALV Allianz SE VNA O.N. March 04, 2026
Allianz SE operates as a diversified financial services company. It primarily offers property-casualty insurance, life/health insurance, and asset management.
The property-casualty segment provides various insurance types, including motor, accident, and property coverage for private and corporate clients. This sector is characterized by underwriting risk and claims management.
The life/health segment offers individual and group life and health insurance products, such as annuities and long-term care. Life insurance companies manage long-term liabilities and investment portfolios.
The asset management segment provides institutional and retail clients with diverse investment products, including equity, fixed income, and alternative investments like real estate. Asset management firms generate revenue through management fees based on assets under management.
Allianz also has a corporate and other segment that includes banking services. For further in-depth analysis of Allianzs financial performance and market position, consider exploring ValueRay.
Headlines to watch out for
- Global interest rate fluctuations impact investment income
- Catastrophe losses increase property-casualty claims
- Regulatory changes affect insurance product profitability
- Asset management fees sensitive to market performance
- Economic slowdowns reduce demand for insurance products
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 10.78b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.99 > 1.0 |
| NWC/Revenue: 21.69% < 20% (prev 48.00%; Δ -26.31% < -1%) |
| CFO/TA 0.02 > 3% & CFO 20.14b > Net Income 10.78b |
| Net Debt (-29.85b) to EBITDA (16.30b): -1.83 < 3 |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last quarter (376.6m) vs 12m ago -2.89% < -2% |
| Gross Margin: 83.04% > 18% (prev 0.89%; Δ 8.22k% > 0.5%) |
| Asset Turnover: 13.31% > 50% (prev 12.50%; Δ 0.81% > 0%) |
| Interest Coverage Ratio: 1.07 > 6 (EBITDA TTM 16.30b / Interest Expense TTM 15.00b) |
Altman Z'' 0.45
| A: 0.03 (Total Current Assets 29.85b - Total Current Liabilities 0.0) / Total Assets 1024.28b |
| B: 0.04 (Retained Earnings 36.24b / Total Assets 1024.28b) |
| C: 0.02 (EBIT TTM 16.02b / Avg Total Assets 1034.43b) |
| D: 0.04 (Book Value of Equity 37.41b / Total Liabilities 957.93b) |
| Altman-Z'' Score: 0.45 = B |
Beneish M
| DSRI: none (Receivables none/8.08b, Revenue 137.66b/130.52b) |
| GMI: 1.07 (GM 83.04% / 88.50%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.05 (Revenue 137.66b / 130.52b) |
| TATA: -0.01 (NI 10.78b - CFO 20.14b) / TA 1024.28b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of ALV shares?
As of March 17, 2026, the stock is trading at EUR 359.50 with a total of 701,087 shares traded.
Over the past week, the price has changed by +4.45%, over one month by -3.46%, over three months by -6.21% and over the past year by +5.93%.
Over the past week, the price has changed by +4.45%, over one month by -3.46%, over three months by -6.21% and over the past year by +5.93%.
Is ALV a buy, sell or hold?
Allianz SE VNA O.N. has no consensus analysts rating.
What are the forecasts/targets for the ALV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 365 | 1.5% |
| Analysts Target Price | - | - |
ALV Fundamental Data Overview March 15, 2026
Market Cap USD = 160.45b (140.11b EUR * 1.1452 EUR.USD)
P/E Trailing = 13.9447
P/E Forward = 11.6009
P/S = 1.2089
P/B = 2.1142
P/EG = 1.4319
Revenue TTM = 137.66b EUR
EBIT TTM = 16.02b EUR
EBITDA TTM = 16.30b EUR
Long Term Debt = 66.15b EUR (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -29.85b EUR (from netDebt column, last quarter)
Enterprise Value = 110.26b EUR (140.11b + (null Debt) - CCE 29.85b)
Interest Coverage Ratio = 1.07 (Ebit TTM 16.02b / Interest Expense TTM 15.00b)
EV/FCF = 5.71x (Enterprise Value 110.26b / FCF TTM 19.31b)
FCF Yield = 17.51% (FCF TTM 19.31b / Enterprise Value 110.26b)
FCF Margin = 14.03% (FCF TTM 19.31b / Revenue TTM 137.66b)
Net Margin = 7.83% (Net Income TTM 10.78b / Revenue TTM 137.66b)
Gross Margin = 83.04% ((Revenue TTM 137.66b - Cost of Revenue TTM 23.34b) / Revenue TTM)
Gross Margin QoQ = 82.90% (prev 84.22%)
Tobins Q-Ratio = 0.11 (Enterprise Value 110.26b / Total Assets 1024.28b)
Interest Expense / Debt = unknown (Interest Expense 184.0m / Debt none)
Taxrate = 25.79% (980.0m / 3.80b)
NOPAT = 11.89b (EBIT 16.02b * (1 - 25.79%))
Current Ratio = unknown (Total Current Assets 29.85b / Total Current Liabilities 0.0)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -1.83 (Net Debt -29.85b / EBITDA 16.30b)
Debt / FCF = -1.55 (Net Debt -29.85b / FCF TTM 19.31b)
Total Stockholder Equity = 60.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.04% (Net Income 10.78b / Total Assets 1024.28b)
RoE = 17.77% (Net Income TTM 10.78b / Total Stockholder Equity 60.63b)
RoCE = 12.64% (EBIT 16.02b / Capital Employed (Equity 60.63b + L.T.Debt 66.15b))
RoIC = 17.72% (NOPAT 11.89b / Invested Capital 67.08b)
WACC = 6.97% (E(140.11b)/V(140.11b) * Re(6.97%) + (debt-free company))
Discount Rate = 6.97% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.91%
[DCF] Terminal Value 84.69% ; FCFF base≈23.58b ; Y1≈29.09b ; Y5≈49.54b
[DCF] Fair Price = 2.82k (EV 1055.97b - Net Debt -29.85b = Equity 1085.82b / Shares 385.6m; r=6.97% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 57.38 | EPS CAGR: 55.79% | SUE: 0.56 | # QB: 0
Revenue Correlation: -7.57 | Revenue CAGR: -4.10% | SUE: -1.59 | # QB: 0
EPS next Year (2026-12-31): EPS=31.10 | Chg7d=+0.530 | Chg30d=+0.566 | Revisions Net=+2 | Growth EPS=+7.9% | Growth Revenue=+4.2%
P/E Trailing = 13.9447
P/E Forward = 11.6009
P/S = 1.2089
P/B = 2.1142
P/EG = 1.4319
Revenue TTM = 137.66b EUR
EBIT TTM = 16.02b EUR
EBITDA TTM = 16.30b EUR
Long Term Debt = 66.15b EUR (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -29.85b EUR (from netDebt column, last quarter)
Enterprise Value = 110.26b EUR (140.11b + (null Debt) - CCE 29.85b)
Interest Coverage Ratio = 1.07 (Ebit TTM 16.02b / Interest Expense TTM 15.00b)
EV/FCF = 5.71x (Enterprise Value 110.26b / FCF TTM 19.31b)
FCF Yield = 17.51% (FCF TTM 19.31b / Enterprise Value 110.26b)
FCF Margin = 14.03% (FCF TTM 19.31b / Revenue TTM 137.66b)
Net Margin = 7.83% (Net Income TTM 10.78b / Revenue TTM 137.66b)
Gross Margin = 83.04% ((Revenue TTM 137.66b - Cost of Revenue TTM 23.34b) / Revenue TTM)
Gross Margin QoQ = 82.90% (prev 84.22%)
Tobins Q-Ratio = 0.11 (Enterprise Value 110.26b / Total Assets 1024.28b)
Interest Expense / Debt = unknown (Interest Expense 184.0m / Debt none)
Taxrate = 25.79% (980.0m / 3.80b)
NOPAT = 11.89b (EBIT 16.02b * (1 - 25.79%))
Current Ratio = unknown (Total Current Assets 29.85b / Total Current Liabilities 0.0)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -1.83 (Net Debt -29.85b / EBITDA 16.30b)
Debt / FCF = -1.55 (Net Debt -29.85b / FCF TTM 19.31b)
Total Stockholder Equity = 60.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.04% (Net Income 10.78b / Total Assets 1024.28b)
RoE = 17.77% (Net Income TTM 10.78b / Total Stockholder Equity 60.63b)
RoCE = 12.64% (EBIT 16.02b / Capital Employed (Equity 60.63b + L.T.Debt 66.15b))
RoIC = 17.72% (NOPAT 11.89b / Invested Capital 67.08b)
WACC = 6.97% (E(140.11b)/V(140.11b) * Re(6.97%) + (debt-free company))
Discount Rate = 6.97% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.91%
[DCF] Terminal Value 84.69% ; FCFF base≈23.58b ; Y1≈29.09b ; Y5≈49.54b
[DCF] Fair Price = 2.82k (EV 1055.97b - Net Debt -29.85b = Equity 1085.82b / Shares 385.6m; r=6.97% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 57.38 | EPS CAGR: 55.79% | SUE: 0.56 | # QB: 0
Revenue Correlation: -7.57 | Revenue CAGR: -4.10% | SUE: -1.59 | # QB: 0
EPS next Year (2026-12-31): EPS=31.10 | Chg7d=+0.530 | Chg30d=+0.566 | Revisions Net=+2 | Growth EPS=+7.9% | Growth Revenue=+4.2%